Newest first. 5.2k questions across 107 tags.
This matters because it predicts what a related molecule should do. Please show the division. I want to check my own against yours. I would like the general form as…
Conditions: SUSTAIN-6 · dizziness · 60 mg. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
Conditions: Homopeptide · Zhuhai Kerui Biotechnology. I would like the axes of comparison first and the recommendation second. I have tried the first option and it…
This came up because two published schedules for the same agent differ. I would like to know the limits of what can be inferred from this. What I am trying to avoid…
For reference: cystatin C · three weeks · a GLP-1 receptor agonist. An unexpected observation, and I would like a differential rather than reassurance. The conditions…
For reference: 97.1% · chromatogram. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am being…
For reference: liraglutide · SUSTAIN-6. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have tried to…
The particulars: 15 mg · three weeks · fatigue. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have tried…
For reference: TRIUMPH-1 · 20 mg. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am being…
The specifics, since they change the answer: peptide mapping · semaglutide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have…
The specifics, since they change the answer: Tianjin · the Netherlands. I want to understand what this actually establishes, as opposed to what it is being used to…
Setup, so nobody has to ask: orforglipron · 2 mg/mL. I have worked this out and I would like someone to find the error, because I suspect there is one. My working so…
What I am working with: aggregation · a GLP-1 receptor agonist · 40 °C. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make…
My employer plan's anti-obesity criteria include a line I cannot parse: coverage requires "documented participation in a comprehensive weight management programme…
Stated plainly: 20 units · 2 mg/mL. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory. What I have…
Details up front: TRIUMPH-3 · dulaglutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
Numbers first: 97.1% · Janoshik · 96.8%. Before I write this off, I want to check whether it is a known failure mode. I have the lot number, the certificate and the…
Numbers first: a GLP-1 receptor agonist · twenty-one days. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay…
Numbers first: WWB · dulaglutide. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am interested…
Details up front: eGFR · six weeks · oral semaglutide. Before I write this off, I want to check whether it is a known failure mode. I have the lot number, the…
This matters because it predicts what a related molecule should do. This is one of those things that everyone repeats and nobody derives. This matters practically,…
The case in front of me: STEP 1 · liraglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
The case in front of me: CPC · Shanghai Wibson Biotechnology. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to…
Conditions: 112 kg · 1,100 kcal. I want the working, not the result — I need to be able to redo it with different numbers. I care about the precision as well as the…